Jacobs Levy Equity Management’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-89,641	Closed	-$626K	–	1060
2022 Q2	$626K	Buy	+89,641	New	+$626K	﹤0.01%	833
2021 Q3	–	Sell	-37,417	Closed	-$901K	–	1065
2021 Q2	$901K	Buy	+37,417	New	+$901K	0.01%	757